TradeFlare's AI research teams analysed PTCT on 11 market nights between April 27, 2026 and August 6, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.
| Date | Verdict | Price | Target / stop | 5 days later | 20 days later | Why (that night) |
|---|---|---|---|---|---|---|
| August 6, 2026 | BUY | $69.21 | — / — | +1.6% | +0.8% | Continued positive sentiment driven by strong Sephience performance and earnings beats. |
| August 5, 2026 | BUY | $69.10 | $79.69 / $58.74 | +5.0% | +3.7% | The post-earnings drift signal suggests a multi-week opportunity. |
| August 4, 2026 | BUY | $68.11 | $76.17 / $57.90 | +6.7% | +2.1% | The post-earnings drift signal suggests a sustained upward move is possible. |
| August 3, 2026 | BUY | $68.01 | — / — | +9.6% | +2.1% | The current market and stock setup does not warrant a trade. |
| July 21, 2026 | HOLD | $78.01 | — / — | -4.0% | -7.5% | Analyst upgrades and index inclusions provide some positive tailwinds. |
| July 20, 2026 | BUY | $78.59 | — / — | -2.8% | -6.6% | The current market and stock setup does not warrant a buy. |
| July 17, 2026 | SELL | $78.52 | — / — | -2.2% | -8.8% | The scanner triggered a short-term mean-reversion signal, but the overall risk profile and mixed team signals do not support a new entry. |
| July 16, 2026 | BUY | $78.84 | $85.08 / $62.65 | -0.1% | -8.3% | The fundamental and sentiment tailwinds suggest a sustained upward move, but technicals require time to confirm. |
| July 15, 2026 | BUY | $78.06 | — / — | -0.6% | -7.9% | Positive news sentiment driven by strong Q1 earnings and favorable outlook for Sephience. |
| April 28, 2026 | HOLD | $69.22 | $77.46 / $58.84 | -7.4% | +0.6% | The current market regime is neutral, and PTCT lacks a clear catalyst for a directional trade. |
| April 27, 2026 | BUY | $68.23 | — / — | -5.4% | -2.3% | Positive clinical trial results for new drug candidates. |
Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.